ETF Managers Group’s Co-Diagnostics CODX Stock Holding History

ETF Managers Group’s Portfolio CODX Stock Details CODX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$14.5K	Buy	+327	New	+$26.2K	﹤0.01%	681
2022 Q4	–	Sell	-332	Closed	-$32K	–	553
2022 Q3	$32K	Sell	332 -26	-7%	-$3.64K	﹤0.01%	681
2022 Q2	$58K	Buy	358 +63	+21%	+$9.58K	﹤0.01%	701
2022 Q1	$56K	Buy	295 +4	+1%	+$828	﹤0.01%	653
2021 Q4	$79K	Sell	291 -48	-14%	-$12.6K	﹤0.01%	649
2021 Q3	$99K	Buy	339 +57	+20%	+$16.6K	﹤0.01%	641
2021 Q2	$75K	Sell	282 -7	-2%	-$1.8K	﹤0.01%	630
2021 Q1	$74K	Sell	289 -169	-37%	-$67.5K	﹤0.01%	647
2020 Q4	$134K	Sell	458 -66	-13%	-$24.5K	﹤0.01%	590
2020 Q3	$219K	Buy	524 +252	+93%	+$129K	0.01%	570
2020 Q2	$142K	Buy	+272	New	+$124K	0.01%	569

Other funds holding CODX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

ETF Managers Group's CODX Position: Q1 2023 in Review

ETF Managers Group opened a new position in Co-Diagnostics (CODX) in Q1 2023: 327 shares worth $14.5K. The stake represents ﹤0.01% of the portfolio and ranks #681 among its holdings. This is a return to the name: ETF Managers Group previously reported a position in CODX as recently as Q3 2022.

ETF Managers Group first reported a position in CODX in Q2 2020 and has held it in 11 quarters since. The position peaked at $219K in Q3 2020. 51 funds tracked by Wall St. Rank hold CODX as of Q1 2023.

ETF Managers Group held 327 shares of Co-Diagnostics worth $14.5K as of Q1 2023.
Co-Diagnostics was a new ETF Managers Group position in Q1 2023.
Co-Diagnostics made up ﹤0.01% of ETF Managers Group's portfolio in Q1 2023, its #681 holding.
ETF Managers Group first reported a position in Co-Diagnostics in Q2 2020 and has held it in 11 quarters since.
ETF Managers Group's Co-Diagnostics position peaked at $219K in Q3 2020.
51 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.